Lansoprazole

Category: pharmacological

Aliases: Prevacid

Pharmacological Mechanism

Irreversible H+/K+-ATPase inhibitor. CYP2C19 + CYP3A4 substrate. Available OTC; commonly co-administered with NSAIDs to mitigate gastric ulcers.

Half-Life (t½)

PO: 2h

Dosing Guidelines

• PO: Typical 30mg (Range: 15 - 30 mg)

Target Organ Systems

• digestive